ASHPOfficial

In the wake of drug shortages, patients with a high requirement for sedation coupled with an increase in the number of patients who have renal failure due to complications to COVID-19, pharmacists must be ever vigilant on managing patient’s mediation regimens and monitoring for toxicities.  With that in mind, we sit down with our content matter experts to talk about managing patients who might be at risk for developing toxicities due to the excipients found in drugs and how pharmacists can play an important role in preventing these adverse events. 

 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The speakers will cover a variety of hepatitis C topics, including the current landscape, the evolution of therapies available, the changing role of the pharmacist, and where they see the future of this therapeutic area.  

 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The ASHP Business Recovery Toolkit for Hospital and Health System Pharmacy shares the results of virtual roundtables were conducted in the first week of May 2020 with pharmacy leaders from across the United States to share early efforts in business recovery planning. David Chen, Assistant Vice President for Pharmacy Leadership and Planning sits down Vicki Basalyga to discuss how the toolkit was developed and the actions pharmacy leaders can take from this toolkit to recover from this pandemic and leverage the strengths of our profession to care for patients and support fiscal health for the most optimal outcomes possible.

 

 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Dr. Scott Nelson and Dr. Colin Walsh discuss with William Zellmer, Contributing Editor for AJHP, the role of artificial intelligence in pharmacy and its application to the medication-use process. The report under discussion will appear in the October 1, 2020, issue of AJHP.

Recorded July 15, 2020.

AJHP is the official journal of the American Society of Health-System Pharmacists.

www.ajhpvoices.org

Dr. Debra Wagner and Dr. Karen Durant discuss with William Zellmer, Contributing Editor for AJHP, the pharmacy dimensions of planning a field hospital in preparation for a second surge of COVID-19 cases. The article under discussion will appear in the November 1, 2020, issue of AJHP.

Recorded July 9, 2020.

AJHP is the official journal of the American Society of Health-System Pharmacists.

www.ajhpvoices.org

In this podcast Vicki Basalyga ASHP Director of Clinical Specialists and Scientists discusses with Hannah Vanderpool ASHP Vice President of Member Relations and Gina Luchen ASHP Director of Academic programs about the launch of ASHP’s newest Section of Pharmacy Educators.

 

 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode of Truth in Transformation, host Paul Abramowitz, ASHP CEO, talks with ASHP President Tom Johnson about how to stand in your truth — the concept of being honest about your strengths. The ASHP leaders speak to listeners about ways pharmacy professionals can stand in their truth to step into more prominent roles on the healthcare team.

 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Dr. Eric Tichy and Dr. Matthew Rim discuss with William Zellmer, Contributing Editor for AJHP, the 2019 trends in prescription drug expenditures and projections for 2020. The report under discussion will appear in the August 1, 2020, issue of AJHP.

Recorded June 8, 2020.

AJHP is the official journal of the American Society of Health-System Pharmacists.

www.ajhpvoices.org

In response to the COVID-19 pandemic, telehealth pharmacy services have been implemented in many ambulatory care clinics.  Telehealth helps to provide continuity of care for patients, however, there are many elements that must be taken into consideration when providing services.  This podcast highlights technology platforms used by three ambulatory care pharmacists.  The discussion includes creating a workflow, patient education, and trial and error experienced with technology.  

 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.